Alerce Medical Co-Invest I, L.P. registered an exempt securities offering with an indefinite size and $0 sold. Investors have a record showing no securities sold, while the vehicle is identified as a Delaware limited Partnership and pooled Private Equity fund.
Key Highlights
- Alerce Medical Co-Invest I, L.P. is identified as a Delaware limited partnership and pooled Investment fund.
- Muneer A. Satter is named executive officer and linked to the general-partner structure.
- The notice lists the offering amount as $Indefinite and reports $0 sold.
Alerce Medical Co-Invest I, L.P. filed an exempt securities offering with an offering amount of $Indefinite and $0 sold. The notice is dated September 10, 2026, and identifies Alerce as a Delaware limited partnership.
Indefinite Offering Records No Sales
Muneer A. Satter is named as executive officer at the same Chicago address. The notice also identifies Satter as Trustee of the managing member of the general partner of the general partner of Alerce. The exemption references listed for the offering are 06c, 3C and 3C.7. Alerce Medical Co-Invest I, L.P. is identified in the notice, and the reported amount sold remains $0.
FAQs
Q: What is the Alerce Medical Co-Invest I offering amount?
A: The filing lists the exempt securities offering amount as $Indefinite. It reports that Alerce Medical Co-Invest I, L.P. had sold $0 at the time of the notice.
Q: Were any securities sold in the Alerce Medical offering?
A: The notice records $0 sold. Alerce Medical Co-Invest I, L.P. is identified as a pooled investment fund and private equity fund.
Q: Who is connected to Alerce Medical Co-Invest I, L.P.?
A: Muneer A. Satter is named executive officer. He is also identified as trustee of the managing member of the general partner of the general partner.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.